Fast-acting corticosteroid hormone formulated based on Dexamethasone 21 Disodium phosphate.
|Dexamethasone disodium phosphate:||2.6 g.|
|Excipients csp:||100 ml.|
Anti-inflammatory, antirheumatic, antiallergic.
Allergic states, allergic dermatitis, atopic dermatitis, contact dermatitis, erythema, hypersensitivity reactions, autoimmune diseases, aspiration pneumonia, bronchospasm or bronchial asthma, allergic and inflammatory ophthalmic processes, traumatisms, spinal cord compression syndrome, rachialgia, neuralgia , myalgias, neuropathies, arthropathies, myositis, bursitis, tendonitis, synovitis.
Supportive therapy in mastitis, metritis, retention of placenta and endotoxic shock.
The administration of corticosteroids is contraindicated in infectious mycotic, bacterial and viral processes unless the corresponding anti-infective treatment is established.
Do not administer to patients with digestive ulcers, renal insufficiency, hepatic insufficiency, congestive heart failure, bone fractures, osteoporosis, acute infosura, degenerative ocular disease, corneal ulcer, tuberculosis, paratuberculosis, uraemic syndrome, diabetes mellitus and glaucoma.
Use with caution in patients with hypertension, cardiac ischemia, arrhythmia, tachycardia, and hyperthyroidism.
Do not administer to females in the last third of gestation. Children of mothers treated for prolonged periods during breastfeeding may have adrenal suppression.
RESTRICTIONS OF USE
Time that must elapse between the last day of treatment and the sacrifice of the animal for human consumption: cattle, sheep and swine = 7 days.
Do not administer in equines intended for human consumption.
Do not administer to dairy cattle whose production is intended for human consumption.
SIDE EFFECTS AND ADVERSE REACTIONS
Retention of sodium and water, loss of potassium, hypertension, heart failure, muscle weakness, reduction of muscle mass, fracture of long bones, osteoporosis, peptic ulcer, negative nitrogen balance.
In dogs can occur polyphagia and polyuria, weight gain, changes in the coat, vomiting, diarrhea, gastric ulcers, euphoria and behavior changes.
Prolonged use of corticosteroids may cause Cushing’s syndrome.
Administer intramuscularly, subcutaneously and intravenously:
Equine, bovine, ovine, porcine: 0.25 to 0.50 ml / 50 kg of weight.
Canines and felines: 0.25 to 1 ml / 10 kg of weight.
The dose can be repeated every 24 hours according to the evolution of symptoms and the criteria of the acting professional, up to 5 days.
Intraarticular, intrabussic, intrasynovial and soft tissues injection: 1 to 2 ml.
Intralesional injection: 0.2 ml per application point.